应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01244 3D MEDICINES
未开盘 05-06 16:08:49
6.440
-0.260
-3.88%
最高
6.910
最低
6.440
成交量
78.50万
今开
6.740
昨收
6.700
日振幅
7.01%
总市值
16.63亿
流通市值
16.63亿
总股本
2.58亿
成交额
522.14万
换手率
0.30%
流通股本
2.58亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
3D MEDICINES(01244)下跌5.09%,报6.53元/股
金融界 · 05-03
3D MEDICINES(01244)下跌5.09%,报6.53元/股
3D MEDICINES盘中异动 早盘股价大跌5.09%报6.530港元
自选股智能写手 · 05-03
3D MEDICINES盘中异动 早盘股价大跌5.09%报6.530港元
3D MEDICINES盘中异动 早盘股价大涨5.05%
自选股智能写手 · 05-02
3D MEDICINES盘中异动 早盘股价大涨5.05%
3D MEDICINES(01244)股价上升5.046%,现价港币$6.87
阿斯达克财经 · 05-02
3D MEDICINES(01244)股价上升5.046%,现价港币$6.87
3D MEDICINES(01244)上涨5.14%,报6.54元/股
金融界 · 04-29
3D MEDICINES(01244)上涨5.14%,报6.54元/股
3D MEDICINES盘中异动 下午盘股价大涨5.31%报6.550港元
自选股智能写手 · 04-29
3D MEDICINES盘中异动 下午盘股价大涨5.31%报6.550港元
迈博药业-B盘中异动 股价大跌7.98%
自选股智能写手 · 04-25
迈博药业-B盘中异动 股价大跌7.98%
3D MEDICINES(01244)上涨5.46%,报6.18元/股
金融界 · 04-25
3D MEDICINES(01244)上涨5.46%,报6.18元/股
3D MEDICINES(01244)股价上升5.29%,现价港币$6.17
阿斯达克财经 · 04-25
3D MEDICINES(01244)股价上升5.29%,现价港币$6.17
3D MEDICINES盘中异动 股价大涨5.29%报5.950港元
自选股智能写手 · 04-24
3D MEDICINES盘中异动 股价大涨5.29%报5.950港元
3D MEDICINES盘中异动 早盘股价大跌5.25%报5.401港元
自选股智能写手 · 04-16
3D MEDICINES盘中异动 早盘股价大跌5.25%报5.401港元
3D MEDICINES(01244)股价下跌5.088%,现价港币$5.41
阿斯达克财经 · 04-16
3D MEDICINES(01244)股价下跌5.088%,现价港币$5.41
3D MEDICINES(01244)上涨5.47%,报5.78元/股
金融界 · 04-12
3D MEDICINES(01244)上涨5.47%,报5.78元/股
3D MEDICINES盘中异动 下午盘股价大涨5.27%报5.770港元
自选股智能写手 · 04-12
3D MEDICINES盘中异动 下午盘股价大涨5.27%报5.770港元
3D MEDICINES(01244)股价上升5.109%,现价港币$5.76
阿斯达克财经 · 04-12
3D MEDICINES(01244)股价上升5.109%,现价港币$5.76
3D MEDICINES(01244.HK)向高管及核心员工授予1280万份期权,激励提升业绩及长远发展
和讯网 · 04-05
3D MEDICINES(01244.HK)向高管及核心员工授予1280万份期权,激励提升业绩及长远发展
3D MEDICINES(01244)授出1280.285万份股份期权
智通财经 · 04-05
3D MEDICINES(01244)授出1280.285万份股份期权
3D MEDICINES(01244)下跌6.35%,报5.6元/股
金融界 · 04-05
3D MEDICINES(01244)下跌6.35%,报5.6元/股
3D MEDICINES盘中异动 急速下跌5.70%
自选股智能写手 · 04-05
3D MEDICINES盘中异动 急速下跌5.70%
公司概况
公司名称:
3D MEDICINES
所属市场:
SEHK
上市日期:
--
主营业务:
3D Medicines Biotechnology Shanghai Co Ltd 是一家中国公司,主要从事商业化肿瘤产品和候选药物的研发。该公司的主要产品管线包括免疫肿瘤单一疗法、作用机制适合在管线内组合的候选药物以及疼痛管理资产。该公司核心产品为皮下注射抗PD-L1药物恩沃利单抗。该公司还有多个处于临床阶段的候选药物,包括肽癌疫苗3D189、GAS6诱饵受体3D229、成纤维细胞生长因子受体(FGFR)3D185等。该公司主要在国内市场开展业务。
发行价格:
--
{"stockData":{"symbol":"01244","market":"HK","secType":"STK","nameCN":"3D MEDICINES","latestPrice":6.44,"timestamp":1714982929014,"preClose":6.7,"halted":0,"volume":785000,"delay":0,"floatShares":258207000,"shares":258207000,"eps":-2.4887197,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.26,"latestTime":"05-06 16:08:49","open":6.74,"high":6.91,"low":6.44,"amount":5221400,"amplitude":0.070149,"askPrice":6.44,"askSize":5500,"bidPrice":6.43,"bidSize":4000,"shortable":3,"etf":0,"ttmEps":-2.488719615414686,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1715045400000},"adr":0,"listingDate":1671033600000,"adjPreClose":6.7,"openAndCloseTimeList":[[1714959000000,1714968000000],[1714971600000,1714982400000]],"volumeRatio":0.9490992626210759,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01244/wiki","defaultTab":"wiki","newsList":[{"id":"2432990221","title":"3D MEDICINES(01244)下跌5.09%,报6.53元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2432990221","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2432990221?lang=zh_cn&edition=full","pubTime":"2024-05-03 11:16","pubTimestamp":1714706192,"startTime":"0","endTime":"0","summary":"5月3日,3D MEDICINES(01244)盘中下跌5.09%,截至11:16,报6.53元/股,成交143.66万元。3D Medicines Inc.是一家专注于肿瘤治疗领域的医药公司,主要业务是为全球肿瘤患者开发肿瘤药物,产品线包括12款具有临床价值的创新候选药物。公司目前拥有约250人的新药研发、生产和商业化的团队,其中8款药物已进入临床开发或商业化阶段,包括已获国家药品监督管理局批准在中国上市的恩维达,以及已获FDA批准开展全球III期临床研究的3D189和3D229。截至2023年年报,3D MEDICINES营业总收入6.35亿元、净利润-5.25亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/05/03111640513688.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2432185849","title":"3D MEDICINES盘中异动 早盘股价大跌5.09%报6.530港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432185849","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432185849?lang=zh_cn&edition=full","pubTime":"2024-05-03 11:16","pubTimestamp":1714706185,"startTime":"0","endTime":"0","summary":"2024年05月03日早盘11时16分,3D MEDICINES股票出现波动,股价快速下挫5.09%。截至发稿,该股报6.530港元/股,成交量21.75万股,换手率0.08%,振幅5.96%。3D MEDICINES股票所在的生物技术行业中,整体跌幅为0.75%。其相关个股中,美因基因、三叶草生物-B、和铂医药-B涨幅较大,振幅较大的相关个股有圣诺医药-B、药明合联、美因基因,振幅分别为17.65%、13.02%、12.83%。3D MEDICINES公司简介:3D Medicines Inc是一家主要从事生物制药研发及商业化业务的中国投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050311162587e856de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050311162587e856de&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432909686","title":"3D MEDICINES盘中异动 早盘股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432909686","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432909686?lang=zh_cn&edition=full","pubTime":"2024-05-02 11:09","pubTimestamp":1714619357,"startTime":"0","endTime":"0","summary":"2024年05月02日早盘11时09分,3D MEDICINES股票出现波动,股价大幅上涨5.05%。截至发稿,该股报6.870港元/股,成交量17.75万股,换手率0.07%,振幅5.50%。3D MEDICINES股票所在的生物技术行业中,整体涨幅为0.98%。其相关个股中,加科思-B、康希诺生物、乐普生物-B涨幅较大,振幅较大的相关个股有加科思-B、基石药业-B、科笛-B,振幅分别为14.20%、11.36%、11.34%。3D MEDICINES公司简介:3D Medicines Inc是一家主要从事生物制药研发及商业化业务的中国投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405021109177a57e5ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405021109177a57e5ce&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432690579","title":"3D MEDICINES(01244)股价上升5.046%,现价港币$6.87","url":"https://stock-news.laohu8.com/highlight/detail?id=2432690579","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2432690579?lang=zh_cn&edition=full","pubTime":"2024-05-02 11:09","pubTimestamp":1714619340,"startTime":"0","endTime":"0","summary":"[上升股]3D MEDICINES(01244) 股价在上午11:09比前收市价上升5.046%,现股价为港币$6.87。至目前为止,今日最高价为$6.87,而最低价为$6.51。总成交量为17.45万股,总成交金额为港币$116.162万。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180112133337750_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180112133337750_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2405022924/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2431008325","title":"3D MEDICINES(01244)上涨5.14%,报6.54元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2431008325","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2431008325?lang=zh_cn&edition=full","pubTime":"2024-04-29 14:35","pubTimestamp":1714372535,"startTime":"0","endTime":"0","summary":"4月29日,3D MEDICINES(01244)盘中上涨5.14%,截至14:35,报6.54元/股,成交807.18万元。3D Medicines Inc.是一家专注于肿瘤治疗领域的医药公司,主要业务是为全球肿瘤患者开发肿瘤药物,产品线包括12款具有临床价值的创新候选药物。公司目前拥有约250人的新药研发、生产和商业化的团队,其中8款药物已进入临床开发或商业化阶段,包括已获国家药品监督管理局批准在中国上市的恩维达,以及已获FDA批准开展全球III期临床研究的3D189和3D229。截至2023年年报,3D MEDICINES营业总收入6.35亿元、净利润-5.25亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/04/29143540463092.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431075508","title":"3D MEDICINES盘中异动 下午盘股价大涨5.31%报6.550港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431075508","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431075508?lang=zh_cn&edition=full","pubTime":"2024-04-29 13:00","pubTimestamp":1714366803,"startTime":"0","endTime":"0","summary":"2024年04月29日下午盘13时00分,3D MEDICINES股票出现异动,股价大幅拉升5.31%。截至发稿,该股报6.550港元/股,成交量80.2万股,换手率0.31%,振幅4.50%。资金方面,该股资金流入341.191万港元,流出97.634万港元。3D MEDICINES股票所在的生物技术行业中,整体涨幅为1.15%。3D MEDICINES公司简介:3D Medicines Inc是一家主要从事生物制药研发及商业化业务的中国投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404291300037924b177&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404291300037924b177&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430450124","title":"迈博药业-B盘中异动 股价大跌7.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430450124","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430450124?lang=zh_cn&edition=full","pubTime":"2024-04-25 11:36","pubTimestamp":1714016200,"startTime":"0","endTime":"0","summary":"2024年04月25日临近午盘11时36分,迈博药业-B股票出现异动,股价急速下跌7.98%。迈博药业-B股票所在的生物技术行业中,整体涨幅为1.41%。其相关个股中,维亚生物、3D MEDICINES、科济药业-B涨幅较大,振幅较大的相关个股有科济药业-B、北海康成-B、来凯医药-B,振幅分别为16.04%、14.89%、14.07%。迈博药业-B公司简介:迈博药业有限公司是一家主要从事研究、开发和生产用于癌症和自身免疫疾病的单克隆抗体药物的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042511364087e83693&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042511364087e83693&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430142144","title":"3D MEDICINES(01244)上涨5.46%,报6.18元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2430142144","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2430142144?lang=zh_cn&edition=full","pubTime":"2024-04-25 09:41","pubTimestamp":1714009264,"startTime":"0","endTime":"0","summary":"4月25日,3D MEDICINES(01244)盘中上涨5.46%,截至09:41,报6.18元/股,成交130.22万元。3D Medicines Inc.是一家专注于肿瘤治疗领域的医药公司,主要业务是为全球肿瘤患者开发肿瘤药物,产品线包括12款具有临床价值的创新候选药物。公司目前拥有约250人的新药研发、生产和商业化的团队,其中8款药物已进入临床开发或商业化阶段,包括已获国家药品监督管理局批准在中国上市的恩维达,以及已获FDA批准开展全球III期临床研究的3D189和3D229。截至2023年年报,3D MEDICINES营业总收入6.35亿元、净利润-5.25亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/04/25094140399053.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430141280","title":"3D MEDICINES(01244)股价上升5.29%,现价港币$6.17","url":"https://stock-news.laohu8.com/highlight/detail?id=2430141280","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2430141280?lang=zh_cn&edition=full","pubTime":"2024-04-25 09:40","pubTimestamp":1714009200,"startTime":"0","endTime":"0","summary":"[上升股]3D MEDICINES(01244) 股价在上午09:40比前收市价上升5.29%,现股价为港币$6.17。至目前为止,今日最高价为$6.17,而最低价为$5.85。总成交量为21.3万股,总成交金额为港币$128.368万。","market":"us","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR240425354/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2429028011","title":"3D MEDICINES盘中异动 股价大涨5.29%报5.950港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429028011","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429028011?lang=zh_cn&edition=full","pubTime":"2024-04-24 14:21","pubTimestamp":1713939682,"startTime":"0","endTime":"0","summary":"2024年04月24日下午盘14时21分,3D MEDICINES股票出现异动,股价快速上涨5.29%。截至发稿,该股报5.950港元/股,成交量90.7万股,换手率0.35%,振幅7.79%。资金方面,该股资金流入250.344万港元,流出184.082万港元。3D MEDICINES股票所在的生物技术行业中,整体涨幅为1.52%。3D MEDICINES公司简介:3D Medicines Biotechnology Shanghai Co Ltd 是一家中国公司,主要从事商业化肿瘤产品和候选药物的研发。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042414212287e831d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042414212287e831d7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427864635","title":"3D MEDICINES盘中异动 早盘股价大跌5.25%报5.401港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427864635","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427864635?lang=zh_cn&edition=full","pubTime":"2024-04-16 10:25","pubTimestamp":1713234346,"startTime":"0","endTime":"0","summary":"2024年04月16日早盘10时25分,3D MEDICINES股票出现异动,股价急速下跌5.25%。截至发稿,该股报5.401港元/股,成交量19.9万股,换手率0.08%,振幅6.84%。资金方面,该股资金流入6.874万港元,流出87.9225万港元。3D MEDICINES股票所在的生物技术行业中,整体跌幅为0.55%。3D MEDICINES公司简介:3D Medicines Biotechnology Shanghai Co Ltd 是一家中国公司,主要从事商业化肿瘤产品和候选药物的研发。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041610254687e80c68&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041610254687e80c68&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427861338","title":"3D MEDICINES(01244)股价下跌5.088%,现价港币$5.41","url":"https://stock-news.laohu8.com/highlight/detail?id=2427861338","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2427861338?lang=zh_cn&edition=full","pubTime":"2024-04-16 10:25","pubTimestamp":1713234300,"startTime":"0","endTime":"0","summary":"[下跌股]3D MEDICINES(01244) 股价在上午10:25比前收市价下跌5.088%,现股价为港币$5.41。至目前为止,今日最高价为$5.79,而最低价为$5.41。总成交量为16.9万股,总成交金额为港币$93.187万。","market":"fut","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180416150425748_s.png","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180416150425748_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2404161386/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2426207302","title":"3D MEDICINES(01244)上涨5.47%,报5.78元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2426207302","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2426207302?lang=zh_cn&edition=full","pubTime":"2024-04-12 14:00","pubTimestamp":1712901623,"startTime":"0","endTime":"0","summary":"4月12日,3D MEDICINES(01244)盘中上涨5.47%,截至14:00,报5.78元/股,成交473.19万元。3D Medicines Inc.是一家专注于肿瘤治疗领域的医药公司,主要业务是为全球肿瘤患者开发肿瘤药物,产品线包括12款具有临床价值的创新候选药物。公司目前拥有约250人的新药研发、生产和商业化的团队,其中8款药物已进入临床开发或商业化阶段,包括已获国家药品监督管理局批准在中国上市的恩维达,以及已获FDA批准开展全球III期临床研究的3D189和3D229。截至2023年年报,3D MEDICINES营业总收入6.35亿元、净利润-5.25亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/04/12140040213515.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2426278550","title":"3D MEDICINES盘中异动 下午盘股价大涨5.27%报5.770港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426278550","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426278550?lang=zh_cn&edition=full","pubTime":"2024-04-12 14:00","pubTimestamp":1712901618,"startTime":"0","endTime":"0","summary":"2024年04月12日下午盘14时00分,3D MEDICINES股票出现异动,股价快速上涨5.27%。3D MEDICINES股票所在的生物技术行业中,整体涨幅为0.04%。消息层面,截至14时00分,3D MEDICINES股票正面舆情新闻比例100%。该信息摘要如下:4月9日报道,根据香港联交所4月9日披露的文件,朱湃于2023年11月9日以每股均价9.44港元增持$3D MEDICINES $2.55万股普通股股份,价值约24.07万港元。增持后,朱湃最新持股数目为1,376.79万股股份,好仓比例由5.32%升至5.33%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412140019861e531e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412140019861e531e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426127866","title":"3D MEDICINES(01244)股价上升5.109%,现价港币$5.76","url":"https://stock-news.laohu8.com/highlight/detail?id=2426127866","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2426127866?lang=zh_cn&edition=full","pubTime":"2024-04-12 14:00","pubTimestamp":1712901600,"startTime":"0","endTime":"0","summary":"[上升股]3D MEDICINES(01244) 股价在下午02:00比前收市价上升5.109%,现股价为港币$5.76。至目前为止,今日最高价为$5.76,而最低价为$5.46。总成交量为82.95万股,总成交金额为港币$465.687万。","market":"other","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180205152547499_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180205152547499_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2404122371/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2425656775","title":"3D MEDICINES(01244.HK)向高管及核心员工授予1280万份期权,激励提升业绩及长远发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2425656775","media":"和讯网","top":-1,"share":"https://www.laohu8.com/m/news/2425656775?lang=zh_cn&edition=full","pubTime":"2024-04-05 22:53","pubTimestamp":1712328810,"startTime":"0","endTime":"0","summary":"快讯正文3D MEDICINES授予1280.29万份股份期权4月5日,3D MEDICINES宣布,依据2023年股份期权计划,于2024年4月5日公司已授予12,802,850份股份期权。期权实际生效需待承授人接受。此次股份期权授予涉及公司高管及核心员工,旨在激励团队提升业绩,实现公司长远发展目标。股份期权计划有助于吸引和留住人才,提高员工的归属感和忠诚度。二级市场投资者需关注此次期权授予的潜在影响,以及3D MEDICINES未来业绩表现。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040523254787e21c20&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040523254787e21c20&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425877569","title":"3D MEDICINES(01244)授出1280.285万份股份期权","url":"https://stock-news.laohu8.com/highlight/detail?id=2425877569","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2425877569?lang=zh_cn&edition=full","pubTime":"2024-04-05 22:14","pubTimestamp":1712326492,"startTime":"0","endTime":"0","summary":"智通财经APP讯,3D MEDICINES(01244)发布公告,于2024年4月5日,公司已根据2023年股份期权计划要约授出合共1280.285万份股份期权,但须待股份期权承授人接纳后方可作实。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1098922.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2425586756","title":"3D MEDICINES(01244)下跌6.35%,报5.6元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2425586756","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2425586756?lang=zh_cn&edition=full","pubTime":"2024-04-05 13:42","pubTimestamp":1712295778,"startTime":"0","endTime":"0","summary":"4月5日,3D MEDICINES(01244)盘中下跌6.35%,截至13:42,报5.6元/股,成交101.96万元。3D Medicines Inc.是一家专注于肿瘤治疗领域的医药公司,主要业务是为全球肿瘤患者开发肿瘤药物,产品线包括12款具有临床价值的创新候选药物。公司目前拥有约250人的新药研发、生产和商业化的团队,其中8款药物已进入临床开发或商业化阶段,包括已获国家药品监督管理局批准在中国上市的恩维达,以及已获FDA批准开展全球III期临床研究的3D189和3D229。截至2023年年报,3D MEDICINES营业总收入6.35亿元、净利润-5.25亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/04/05134240130206.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2425309550","title":"3D MEDICINES盘中异动 急速下跌5.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2425309550","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425309550?lang=zh_cn&edition=full","pubTime":"2024-04-05 10:58","pubTimestamp":1712285934,"startTime":"0","endTime":"0","summary":"2024年04月05日早盘10时58分,3D MEDICINES股票出现异动,股价快速下挫5.70%。截至发稿,该股报5.640港元/股,成交量9.85万股,换手率0.04%,振幅1.84%。3D MEDICINES股票所在的生物技术行业中,整体跌幅为1.39%。其相关个股中,绿竹生物-B、基石药业-B、荣昌生物涨幅较大,振幅较大的相关个股有泰格医药、药明康德、药明巨诺-B,振幅分别为11.73%、9.68%、9.04%。3D MEDICINES公司简介:3D Medicines Biotechnology Shanghai Co Ltd 是一家中国公司,主要从事商业化肿瘤产品和候选药物的研发。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240405105854791ed42b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240405105854791ed42b&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.3d-medicines.com","stockEarnings":[{"period":"1week","weight":-0.0016},{"period":"1month","weight":0.1123},{"period":"3month","weight":0.1009},{"period":"6month","weight":-0.3235},{"period":"1year","weight":-0.9064},{"period":"ytd","weight":-0.1571}],"compareEarnings":[{"period":"1week","weight":0.0468},{"period":"1month","weight":0.1109},{"period":"3month","weight":0.1513},{"period":"6month","weight":0.0575},{"period":"1year","weight":-0.0734},{"period":"ytd","weight":0.0898}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"3D Medicines Biotechnology Shanghai Co Ltd 是一家中国公司,主要从事商业化肿瘤产品和候选药物的研发。该公司的主要产品管线包括免疫肿瘤单一疗法、作用机制适合在管线内组合的候选药物以及疼痛管理资产。该公司核心产品为皮下注射抗PD-L1药物恩沃利单抗。该公司还有多个处于临床阶段的候选药物,包括肽癌疫苗3D189、GAS6诱饵受体3D229、成纤维细胞生长因子受体(FGFR)3D185等。该公司主要在国内市场开展业务。","exchange":"SEHK","name":"3D MEDICINES","nameEN":"3D MEDICINES"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"3D MEDICINES(01244)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供3D MEDICINES(01244)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"3D MEDICINES,01244,3D MEDICINES股票,3D MEDICINES股票老虎,3D MEDICINES股票老虎国际,3D MEDICINES行情,3D MEDICINES股票行情,3D MEDICINES股价,3D MEDICINES股市,3D MEDICINES股票价格,3D MEDICINES股票交易,3D MEDICINES股票购买,3D MEDICINES股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"3D MEDICINES(01244)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供3D MEDICINES(01244)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}